−1.816EUR
−4.70 MEUR
1.22 MEUR
6.56 M
About CHROMOGENICS AB
Sector
Industry
CEO
Fredrik Fränding
Website
Headquarters
Uppsala
Employees (FY)
33
Founded
2002
ISIN
SE0020847481
FIGI
BBG00GD17M47
ChromoGenics AB operates as a holding company, which offers dynamic glass with controllable heat and light transmission and static glass. The firms technology ConverLight provides sustainable solar control for increased indoor comfort and energy efficiency. The company was founded by Claes-Göran Sture Granqvist, Arne Roos, Greger Gustavsson, Gunnar Niklasson and Andris Azens in 2003 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHROMOGENICS AB O.N. stocks are traded under the ticker 384.
Yes, you can track CHROMOGENICS AB O.N. financials in yearly and quarterly reports right on TradingView.
384 net income for the last quarter is −1.48 M EUR, while the quarter before that showed −945.48 K EUR of net income which accounts for −56.99% change. Track more CHROMOGENICS AB O.N. financial stats to get the full picture.
No, 384 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 384 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHROMOGENICS AB O.N. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 33.00 employees. See our rating of the largest employees — is CHROMOGENICS AB O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHROMOGENICS AB O.N. EBITDA is −4.13 M EUR, and current EBITDA margin is −338.29%. See more stats in CHROMOGENICS AB O.N. financial statements.